APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmic Drug Delivery System

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ophthalmic Drug Delivery System Market Analysis and Forecast 2026-2032

5 July 2026215 pages

Choose your research edition.

Industry ResearchOphthalmic Drug Delivery System Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmic Drug Delivery System Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Ophthalmic Drug Delivery System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmic Drug Delivery System Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmic Drug Delivery System Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Ophthalmic Drug Delivery System market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Ophthalmic Drug Delivery System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ophthalmic Drug Delivery System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ophthalmic Drug Delivery System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ophthalmic Drug Delivery System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Ophthalmic Drug Delivery System include Aero Pump GmbH, AptarGroup, Bausch Health, Becton Dickinson & Company, Biocorp Production, Clearside Biomedical, Envisia Therapeutics, EyePoint Pharmaceuticals, Inc. and Gaplast GmbH, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ophthalmic Drug Delivery System, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ophthalmic Drug Delivery System, also provides the sales of main regions and countries. Of the upcoming market potential for Ophthalmic Drug Delivery System, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ophthalmic Drug Delivery System sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ophthalmic Drug Delivery System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ophthalmic Drug Delivery System sales, projected growth trends, production technology, application and end-user industry.

Ophthalmic Drug Delivery System Segment by Company

Aero Pump GmbH

AptarGroup

Bausch Health

Becton Dickinson & Company

Biocorp Production

Clearside Biomedical

Envisia Therapeutics

EyePoint Pharmaceuticals, Inc.

Gaplast GmbH

Gerresheimer

Graybug Vision

Kedalion Therapeutics

Mati Therapeutics, Inc.,

Nemera

Nipro Corporation

Ocular Therapeutix

Ocumedic, Inc.

Owen Mumford

Re-Vana Therapeutics

Santen Pharmaceutical

Silgan Holdings Inc.

Taiwan Liposome

Terumo Corporation

West Pharmaceutical Services, Inc.

Ophthalmic Drug Delivery System Segment by Type

Implantable Ophthalmic Drug Delivery Systems

Particulate Ophthalmic Drug Delivery Systems

Others

Ophthalmic Drug Delivery System Segment by Application

Clinics

Hospitals

Ambulatory Surgical Centers

Others

Ophthalmic Drug Delivery System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Drug Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic Drug Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Drug Delivery System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Ophthalmic Drug Delivery System in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Ophthalmic Drug Delivery System manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ophthalmic Drug Delivery System sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ophthalmic Drug Delivery System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Implantable Ophthalmic Drug Delivery Systems Major Manufacturers Table 3. Particulate Ophthalmic Drug Delivery Systems Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Ophthalmic Drug Delivery System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Clinics Major Manufacturers Table 7. Hospitals Major Manufacturers Table 8. Ambulatory Surgical Centers Major Manufacturers Table 9. Others Major Manufacturers Table 10. Ophthalmic Drug Delivery System Industry Trends Table 11. Ophthalmic Drug Delivery System Industry Drivers Table 12. Ophthalmic Drug Delivery System Industry Opportunities and Challenges Table 13. Ophthalmic Drug Delivery System Industry Restraints Table 14. Global Ophthalmic Drug Delivery System Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Ophthalmic Drug Delivery System Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Ophthalmic Drug Delivery System Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Ophthalmic Drug Delivery System Revenue Market Share by Region (2021-2026) Table 18. Global Ophthalmic Drug Delivery System Revenue Market Share by Region (2027-2032) Table 19. Global Ophthalmic Drug Delivery System Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global Ophthalmic Drug Delivery System Sales by Region (2021-2026) & (k units) Table 21. Global Ophthalmic Drug Delivery System Sales by Region (2027-2032) & (k units) Table 22. Global Ophthalmic Drug Delivery System Sales Market Share by Region (2021-2026) Table 23. Global Ophthalmic Drug Delivery System Sales Market Share by Region (2027-2032) Table 24. Global Ophthalmic Drug Delivery System Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Ophthalmic Drug Delivery System Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Ophthalmic Drug Delivery System Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Ophthalmic Drug Delivery System Sales Market Share by Manufacturers (2021-2026) Table 28. Global Ophthalmic Drug Delivery System Sales Price (USD/unit) of Manufacturers (2021-2026) Table 29. Global Ophthalmic Drug Delivery System Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Ophthalmic Drug Delivery System Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Ophthalmic Drug Delivery System Manufacturers, Product Type & Application Table 32. Global Ophthalmic Drug Delivery System Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Ophthalmic Drug Delivery System by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Ophthalmic Drug Delivery System Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Ophthalmic Drug Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Ophthalmic Drug Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Ophthalmic Drug Delivery System Revenue Market Share by Type (2021-2026) Table 39. Global Ophthalmic Drug Delivery System Revenue Market Share by Type (2027-2032) Table 40. Global Ophthalmic Drug Delivery System Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global Ophthalmic Drug Delivery System Sales by Type (2021-2026) & (k units) Table 42. Global Ophthalmic Drug Delivery System Sales by Type (2027-2032) & (k units) Table 43. Global Ophthalmic Drug Delivery System Sales Market Share by Type (2021-2026) Table 44. Global Ophthalmic Drug Delivery System Sales Market Share by Type (2027-2032) Table 45. Global Ophthalmic Drug Delivery System Price by Type (2021-2026) & (USD/unit) Table 46. Global Ophthalmic Drug Delivery System Price by Type (2027-2032) & (USD/unit) Table 47. Global Ophthalmic Drug Delivery System Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Ophthalmic Drug Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Ophthalmic Drug Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Ophthalmic Drug Delivery System Revenue Market Share by Application (2021-2026) Table 51. Global Ophthalmic Drug Delivery System Revenue Market Share by Application (2027-2032) Table 52. Global Ophthalmic Drug Delivery System Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global Ophthalmic Drug Delivery System Sales by Application (2021-2026) & (k units) Table 54. Global Ophthalmic Drug Delivery System Sales by Application (2027-2032) & (k units) Table 55. Global Ophthalmic Drug Delivery System Sales Market Share by Application (2021-2026) Table 56. Global Ophthalmic Drug Delivery System Sales Market Share by Application (2027-2032) Table 57. Global Ophthalmic Drug Delivery System Price by Application (2021-2026) & (USD/unit) Table 58. Global Ophthalmic Drug Delivery System Price by Application (2027-2032) & (USD/unit) Table 59. Aero Pump GmbH Company Information Table 60. Aero Pump GmbH Business Overview Table 61. Aero Pump GmbH Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 62. Aero Pump GmbH Ophthalmic Drug Delivery System Product Portfolio Table 63. Aero Pump GmbH Recent Development Table 64. AptarGroup Company Information Table 65. AptarGroup Business Overview Table 66. AptarGroup Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. AptarGroup Ophthalmic Drug Delivery System Product Portfolio Table 68. AptarGroup Recent Development Table 69. Bausch Health Company Information Table 70. Bausch Health Business Overview Table 71. Bausch Health Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. Bausch Health Ophthalmic Drug Delivery System Product Portfolio Table 73. Bausch Health Recent Development Table 74. Becton Dickinson & Company Company Information Table 75. Becton Dickinson & Company Business Overview Table 76. Becton Dickinson & Company Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Becton Dickinson & Company Ophthalmic Drug Delivery System Product Portfolio Table 78. Becton Dickinson & Company Recent Development Table 79. Biocorp Production Company Information Table 80. Biocorp Production Business Overview Table 81. Biocorp Production Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Biocorp Production Ophthalmic Drug Delivery System Product Portfolio Table 83. Biocorp Production Recent Development Table 84. Clearside Biomedical Company Information Table 85. Clearside Biomedical Business Overview Table 86. Clearside Biomedical Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Clearside Biomedical Ophthalmic Drug Delivery System Product Portfolio Table 88. Clearside Biomedical Recent Development Table 89. Envisia Therapeutics Company Information Table 90. Envisia Therapeutics Business Overview Table 91. Envisia Therapeutics Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Envisia Therapeutics Ophthalmic Drug Delivery System Product Portfolio Table 93. Envisia Therapeutics Recent Development Table 94. EyePoint Pharmaceuticals, Inc. Company Information Table 95. EyePoint Pharmaceuticals, Inc. Business Overview Table 96. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Product Portfolio Table 98. EyePoint Pharmaceuticals, Inc. Recent Development Table 99. Gaplast GmbH Company Information Table 100. Gaplast GmbH Business Overview Table 101. Gaplast GmbH Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Gaplast GmbH Ophthalmic Drug Delivery System Product Portfolio Table 103. Gaplast GmbH Recent Development Table 104. Gerresheimer Company Information Table 105. Gerresheimer Business Overview Table 106. Gerresheimer Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Gerresheimer Ophthalmic Drug Delivery System Product Portfolio Table 108. Gerresheimer Recent Development Table 109. Graybug Vision Company Information Table 110. Graybug Vision Business Overview Table 111. Graybug Vision Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Graybug Vision Ophthalmic Drug Delivery System Product Portfolio Table 113. Graybug Vision Recent Development Table 114. Kedalion Therapeutics Company Information Table 115. Kedalion Therapeutics Business Overview Table 116. Kedalion Therapeutics Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Kedalion Therapeutics Ophthalmic Drug Delivery System Product Portfolio Table 118. Kedalion Therapeutics Recent Development Table 119. Mati Therapeutics, Inc., Company Information Table 120. Mati Therapeutics, Inc., Business Overview Table 121. Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Product Portfolio Table 123. Mati Therapeutics, Inc., Recent Development Table 124. Nemera Company Information Table 125. Nemera Business Overview Table 126. Nemera Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Nemera Ophthalmic Drug Delivery System Product Portfolio Table 128. Nemera Recent Development Table 129. Nipro Corporation Company Information Table 130. Nipro Corporation Business Overview Table 131. Nipro Corporation Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Nipro Corporation Ophthalmic Drug Delivery System Product Portfolio Table 133. Nipro Corporation Recent Development Table 134. Ocular Therapeutix Company Information Table 135. Ocular Therapeutix Business Overview Table 136. Ocular Therapeutix Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Ocular Therapeutix Ophthalmic Drug Delivery System Product Portfolio Table 138. Ocular Therapeutix Recent Development Table 139. Ocumedic, Inc. Company Information Table 140. Ocumedic, Inc. Business Overview Table 141. Ocumedic, Inc. Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. Ocumedic, Inc. Ophthalmic Drug Delivery System Product Portfolio Table 143. Ocumedic, Inc. Recent Development Table 144. Owen Mumford Company Information Table 145. Owen Mumford Business Overview Table 146. Owen Mumford Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. Owen Mumford Ophthalmic Drug Delivery System Product Portfolio Table 148. Owen Mumford Recent Development Table 149. Re-Vana Therapeutics Company Information Table 150. Re-Vana Therapeutics Business Overview Table 151. Re-Vana Therapeutics Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 152. Re-Vana Therapeutics Ophthalmic Drug Delivery System Product Portfolio Table 153. Re-Vana Therapeutics Recent Development Table 154. Santen Pharmaceutical Company Information Table 155. Santen Pharmaceutical Business Overview Table 156. Santen Pharmaceutical Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 157. Santen Pharmaceutical Ophthalmic Drug Delivery System Product Portfolio Table 158. Santen Pharmaceutical Recent Development Table 159. Silgan Holdings Inc. Company Information Table 160. Silgan Holdings Inc. Business Overview Table 161. Silgan Holdings Inc. Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 162. Silgan Holdings Inc. Ophthalmic Drug Delivery System Product Portfolio Table 163. Silgan Holdings Inc. Recent Development Table 164. Taiwan Liposome Company Information Table 165. Taiwan Liposome Business Overview Table 166. Taiwan Liposome Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 167. Taiwan Liposome Ophthalmic Drug Delivery System Product Portfolio Table 168. Taiwan Liposome Recent Development Table 169. Terumo Corporation Company Information Table 170. Terumo Corporation Business Overview Table 171. Terumo Corporation Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 172. Terumo Corporation Ophthalmic Drug Delivery System Product Portfolio Table 173. Terumo Corporation Recent Development Table 174. West Pharmaceutical Services, Inc. Company Information Table 175. West Pharmaceutical Services, Inc. Business Overview Table 176. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 177. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Product Portfolio Table 178. West Pharmaceutical Services, Inc. Recent Development Table 179. North America Ophthalmic Drug Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 180. North America Ophthalmic Drug Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 181. North America Ophthalmic Drug Delivery System Sales by Type (2021-2026) & (k units) Table 182. North America Ophthalmic Drug Delivery System Sales by Type (2027-2032) & (k units) Table 183. North America Ophthalmic Drug Delivery System Sales Price by Type (2021-2026) & (USD/unit) Table 184. North America Ophthalmic Drug Delivery System Sales Price by Type (2027-2032) & (USD/unit) Table 185. North America Ophthalmic Drug Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 186. North America Ophthalmic Drug Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 187. North America Ophthalmic Drug Delivery System Sales by Application (2021-2026) & (k units) Table 188. North America Ophthalmic Drug Delivery System Sales by Application (2027-2032) & (k units) Table 189. North America Ophthalmic Drug Delivery System Sales Price by Application (2021-2026) & (USD/unit) Table 190. North America Ophthalmic Drug Delivery System Sales Price by Application (2027-2032) & (USD/unit) Table 191. North America Ophthalmic Drug Delivery System Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 192. North America Ophthalmic Drug Delivery System Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 193. North America Ophthalmic Drug Delivery System Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 194. North America Ophthalmic Drug Delivery System Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 195. North America Ophthalmic Drug Delivery System Sales by Country (2021-2026) & (k units) Table 196. North America Ophthalmic Drug Delivery System Sales by Country (2027-2032) & (k units) Table 197. North America Ophthalmic Drug Delivery System Sales Price by Country (2021-2026) & (USD/unit) Table 198. North America Ophthalmic Drug Delivery System Sales Price by Country (2027-2032) & (USD/unit) Table 199. United States Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 200. Canada Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 201. Mexico Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 202. Europe Ophthalmic Drug Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 203. Europe Ophthalmic Drug Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 204. Europe Ophthalmic Drug Delivery System Sales by Type (2021-2026) & (k units) Table 205. Europe Ophthalmic Drug Delivery System Sales by Type (2027-2032) & (k units) Table 206. Europe Ophthalmic Drug Delivery System Sales Price by Type (2021-2026) & (USD/unit) Table 207. Europe Ophthalmic Drug Delivery System Sales Price by Type (2027-2032) & (USD/unit) Table 208. Europe Ophthalmic Drug Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 209. Europe Ophthalmic Drug Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 210. Europe Ophthalmic Drug Delivery System Sales by Application (2021-2026) & (k units) Table 211. Europe Ophthalmic Drug Delivery System Sales by Application (2027-2032) & (k units) Table 212. Europe Ophthalmic Drug Delivery System Sales Price by Application (2021-2026) & (USD/unit) Table 213. Europe Ophthalmic Drug Delivery System Sales Price by Application (2027-2032) & (USD/unit) Table 214. Europe Ophthalmic Drug Delivery System Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 215. Europe Ophthalmic Drug Delivery System Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 216. Europe Ophthalmic Drug Delivery System Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 217. Europe Ophthalmic Drug Delivery System Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 218. Europe Ophthalmic Drug Delivery System Sales by Country (2021-2026) & (k units) Table 219. Europe Ophthalmic Drug Delivery System Sales by Country (2027-2032) & (k units) Table 220. Europe Ophthalmic Drug Delivery System Sales Price by Country (2021-2026) & (USD/unit) Table 221. Europe Ophthalmic Drug Delivery System Sales Price by Country (2027-2032) & (USD/unit) Table 222. Germany Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 223. France Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 224. U.K. Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 225. Italy Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 226. Russia Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 227. Spain Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 228. Netherlands Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 229. Switzerland Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 230. Sweden Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 231. Poland Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 232. China Ophthalmic Drug Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 233. China Ophthalmic Drug Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 234. China Ophthalmic Drug Delivery System Sales by Type (2021-2026) & (k units) Table 235. China Ophthalmic Drug Delivery System Sales by Type (2027-2032) & (k units) Table 236. China Ophthalmic Drug Delivery System Sales Price by Type (2021-2026) & (USD/unit) Table 237. China Ophthalmic Drug Delivery System Sales Price by Type (2027-2032) & (USD/unit) Table 238. China Ophthalmic Drug Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 239. China Ophthalmic Drug Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 240. China Ophthalmic Drug Delivery System Sales by Application (2021-2026) & (k units) Table 241. China Ophthalmic Drug Delivery System Sales by Application (2027-2032) & (k units) Table 242. China Ophthalmic Drug Delivery System Sales Price by Application (2021-2026) & (USD/unit) Table 243. China Ophthalmic Drug Delivery System Sales Price by Application (2027-2032) & (USD/unit) Table 244. Asia Ophthalmic Drug Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 245. Asia Ophthalmic Drug Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 246. Asia Ophthalmic Drug Delivery System Sales by Type (2021-2026) & (k units) Table 247. Asia Ophthalmic Drug Delivery System Sales by Type (2027-2032) & (k units) Table 248. Asia Ophthalmic Drug Delivery System Sales Price by Type (2021-2026) & (USD/unit) Table 249. Asia Ophthalmic Drug Delivery System Sales Price by Type (2027-2032) & (USD/unit) Table 250. Asia Ophthalmic Drug Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 251. Asia Ophthalmic Drug Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 252. Asia Ophthalmic Drug Delivery System Sales by Application (2021-2026) & (k units) Table 253. Asia Ophthalmic Drug Delivery System Sales by Application (2027-2032) & (k units) Table 254. Asia Ophthalmic Drug Delivery System Sales Price by Application (2021-2026) & (USD/unit) Table 255. Asia Ophthalmic Drug Delivery System Sales Price by Application (2027-2032) & (USD/unit) Table 256. Asia Ophthalmic Drug Delivery System Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 257. Asia Ophthalmic Drug Delivery System Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 258. Asia Ophthalmic Drug Delivery System Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 259. Asia Ophthalmic Drug Delivery System Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 260. Asia Ophthalmic Drug Delivery System Sales by Country (2021-2026) & (k units) Table 261. Asia Ophthalmic Drug Delivery System Sales by Country (2027-2032) & (k units) Table 262. Asia Ophthalmic Drug Delivery System Sales Price by Country (2021-2026) & (USD/unit) Table 263. Asia Ophthalmic Drug Delivery System Sales Price by Country (2027-2032) & (USD/unit) Table 264. Japan Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 265. South Korea Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 266. India Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 267. Australia Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 268. Taiwan Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 269. Southeast Asia Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 270. SAMEA Ophthalmic Drug Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 271. SAMEA Ophthalmic Drug Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 272. SAMEA Ophthalmic Drug Delivery System Sales by Type (2021-2026) & (k units) Table 273. SAMEA Ophthalmic Drug Delivery System Sales by Type (2027-2032) & (k units) Table 274. SAMEA Ophthalmic Drug Delivery System Sales Price by Type (2021-2026) & (USD/unit) Table 275. SAMEA Ophthalmic Drug Delivery System Sales Price by Type (2027-2032) & (USD/unit) Table 276. SAMEA Ophthalmic Drug Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 277. SAMEA Ophthalmic Drug Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 278. SAMEA Ophthalmic Drug Delivery System Sales by Application (2021-2026) & (k units) Table 279. SAMEA Ophthalmic Drug Delivery System Sales by Application (2027-2032) & (k units) Table 280. SAMEA Ophthalmic Drug Delivery System Sales Price by Application (2021-2026) & (USD/unit) Table 281. SAMEA Ophthalmic Drug Delivery System Sales Price by Application (2027-2032) & (USD/unit) Table 282. SAMEA Ophthalmic Drug Delivery System Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 283. SAMEA Ophthalmic Drug Delivery System Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 284. SAMEA Ophthalmic Drug Delivery System Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 285. SAMEA Ophthalmic Drug Delivery System Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 286. SAMEA Ophthalmic Drug Delivery System Sales by Country (2021-2026) & (k units) Table 287. SAMEA Ophthalmic Drug Delivery System Sales by Country (2027-2032) & (k units) Table 288. SAMEA Ophthalmic Drug Delivery System Sales Price by Country (2021-2026) & (USD/unit) Table 289. SAMEA Ophthalmic Drug Delivery System Sales Price by Country (2027-2032) & (USD/unit) Table 290. Brazil Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 291. Argentina Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 292. Chile Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 293. Colombia Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 294. Peru Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 295. Saudi Arabia Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 296. Israel Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 297. UAE Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 298. Turkey Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 299. Iran Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 300. Egypt Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Table 301. Key Raw Materials Table 302. Raw Materials Key Suppliers Table 303. Ophthalmic Drug Delivery System Distributors List Table 304. Ophthalmic Drug Delivery System Customers List Table 305. Research Programs/Design for This Report Table 306. Authors List of This Report Table 307. Secondary Sources Table 308. Primary Sources List of Figures Figure 1. Ophthalmic Drug Delivery System Image Figure 2. Global Ophthalmic Drug Delivery System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ophthalmic Drug Delivery System Market Size Share 2021 VS 2025 VS 2032 Figure 4. Implantable Ophthalmic Drug Delivery Systems Image Figure 5. Particulate Ophthalmic Drug Delivery Systems Image Figure 6. Others Image Figure 7. Global Ophthalmic Drug Delivery System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Ophthalmic Drug Delivery System Market Size Share 2021 VS 2025 VS 2032 Figure 9. Clinics Image Figure 10. Hospitals Image Figure 11. Ambulatory Surgical Centers Image Figure 12. Others Image Figure 13. Global Ophthalmic Drug Delivery System Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Figure 15. Global Ophthalmic Drug Delivery System Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Ophthalmic Drug Delivery System Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Ophthalmic Drug Delivery System Revenue Market Share by Region (2021-2032) Figure 18. Global Ophthalmic Drug Delivery System Sales (2021-2032) & (k units) Figure 19. Global Ophthalmic Drug Delivery System Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global Ophthalmic Drug Delivery System Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Ophthalmic Drug Delivery System Sales YoY (2021-2032) & (k units) Figure 22. Europe Ophthalmic Drug Delivery System Sales YoY (2021-2032) & (k units) Figure 23. China Ophthalmic Drug Delivery System Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) Ophthalmic Drug Delivery System Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa Ophthalmic Drug Delivery System Sales YoY (2021-2032) & (k units) Figure 26. Global Ophthalmic Drug Delivery System Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Ophthalmic Drug Delivery System Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Ophthalmic Drug Delivery System Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Ophthalmic Drug Delivery System Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Ophthalmic Drug Delivery System Revenue Market Share by Type (2021-2032) Figure 32. Global Ophthalmic Drug Delivery System Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global Ophthalmic Drug Delivery System Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Ophthalmic Drug Delivery System Sales Market Share by Type (2021-2032) Figure 35. Global Ophthalmic Drug Delivery System Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Ophthalmic Drug Delivery System Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Ophthalmic Drug Delivery System Revenue Market Share by Application (2021-2032) Figure 38. Global Ophthalmic Drug Delivery System Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global Ophthalmic Drug Delivery System Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Ophthalmic Drug Delivery System Sales Market Share by Application (2021-2032) Figure 41. North America Ophthalmic Drug Delivery System Revenue Share by Type (2021-2032) Figure 42. North America Ophthalmic Drug Delivery System Sales Share by Type (2021-2032) Figure 43. North America Ophthalmic Drug Delivery System Revenue Share by Application (2021-2032) Figure 44. North America Ophthalmic Drug Delivery System Sales Share by Application (2021-2032) Figure 45. North America Ophthalmic Drug Delivery System Revenue Share by Country (2021-2032) Figure 46. North America Ophthalmic Drug Delivery System Sales Share by Country (2021-2032) Figure 47. Europe Ophthalmic Drug Delivery System Revenue Share by Type (2021-2032) Figure 48. Europe Ophthalmic Drug Delivery System Sales Share by Type (2021-2032) Figure 49. Europe Ophthalmic Drug Delivery System Revenue Share by Application (2021-2032) Figure 50. Europe Ophthalmic Drug Delivery System Sales Share by Application (2021-2032) Figure 51. Europe Ophthalmic Drug Delivery System Revenue Share by Country (2021-2032) Figure 52. Europe Ophthalmic Drug Delivery System Sales Share by Country (2021-2032) Figure 53. China Ophthalmic Drug Delivery System Revenue Share by Type (2021-2032) Figure 54. China Ophthalmic Drug Delivery System Sales Share by Type (2021-2032) Figure 55. China Ophthalmic Drug Delivery System Revenue Share by Application (2021-2032) Figure 56. China Ophthalmic

Scope & coverage.

Types
  • Implantable Ophthalmic Drug Delivery Systems
  • Particulate Ophthalmic Drug Delivery Systems
  • Others
Applications
  • Clinics
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
Companies covered
  • Aero Pump GmbH
  • AptarGroup
  • Bausch Health
  • Becton Dickinson & Company
  • Biocorp Production
  • Clearside Biomedical
  • Envisia Therapeutics
  • EyePoint Pharmaceuticals, Inc.
  • Gaplast GmbH
  • Gerresheimer
  • Graybug Vision
  • Kedalion Therapeutics
  • Mati Therapeutics, Inc.,
  • Nemera
  • Nipro Corporation
  • Ocular Therapeutix
  • Ocumedic, Inc.
  • Owen Mumford
  • Re-Vana Therapeutics
  • Santen Pharmaceutical
  • Silgan Holdings Inc.
  • Taiwan Liposome
  • Terumo Corporation
  • West Pharmaceutical Services, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ophthalmic Drug Delivery System Market by Type
  3. 1.2.1 Global Ophthalmic Drug Delivery System Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Implantable Ophthalmic Drug Delivery Systems
  5. 1.2.3 Particulate Ophthalmic Drug Delivery Systems
  6. 1.2.4 Others
  7. 1.3 Ophthalmic Drug Delivery System Market by Application
  8. 1.3.1 Global Ophthalmic Drug Delivery System Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Clinics
  10. 1.3.3 Hospitals
  11. 1.3.4 Ambulatory Surgical Centers
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Ophthalmic Drug Delivery System Market Dynamics
  1. 2.1 Ophthalmic Drug Delivery System Industry Trends
  2. 2.2 Ophthalmic Drug Delivery System Industry Drivers
  3. 2.3 Ophthalmic Drug Delivery System Industry Opportunities and Challenges
  4. 2.4 Ophthalmic Drug Delivery System Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Ophthalmic Drug Delivery System Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Ophthalmic Drug Delivery System Revenue by Region
  3. 3.2.1 Global Ophthalmic Drug Delivery System Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ophthalmic Drug Delivery System Revenue by Region (2021-2026)
  5. 3.2.3 Global Ophthalmic Drug Delivery System Revenue by Region (2027-2032)
  6. 3.2.4 Global Ophthalmic Drug Delivery System Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Ophthalmic Drug Delivery System Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Ophthalmic Drug Delivery System Sales by Region
  9. 3.4.1 Global Ophthalmic Drug Delivery System Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Ophthalmic Drug Delivery System Sales by Region (2021-2026)
  11. 3.4.3 Global Ophthalmic Drug Delivery System Sales by Region (2027-2032)
  12. 3.4.4 Global Ophthalmic Drug Delivery System Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Ophthalmic Drug Delivery System Revenue by Manufacturers
  2. 4.1.1 Global Ophthalmic Drug Delivery System Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Ophthalmic Drug Delivery System Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Ophthalmic Drug Delivery System Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ophthalmic Drug Delivery System Sales by Manufacturers
  6. 4.2.1 Global Ophthalmic Drug Delivery System Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Ophthalmic Drug Delivery System Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Ophthalmic Drug Delivery System Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Ophthalmic Drug Delivery System Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Ophthalmic Drug Delivery System Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Ophthalmic Drug Delivery System Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Ophthalmic Drug Delivery System Manufacturers, Product Type & Application
  13. 4.7 Global Ophthalmic Drug Delivery System Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Ophthalmic Drug Delivery System Market CR5 and HHI
  16. 4.8.2 2025 Ophthalmic Drug Delivery System Tier 1, Tier 2, and Tier 3
5 Ophthalmic Drug Delivery System Market by Type
  1. 5.1 Global Ophthalmic Drug Delivery System Revenue by Type
  2. 5.1.1 Global Ophthalmic Drug Delivery System Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Ophthalmic Drug Delivery System Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Ophthalmic Drug Delivery System Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Ophthalmic Drug Delivery System Sales by Type
  6. 5.2.1 Global Ophthalmic Drug Delivery System Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ophthalmic Drug Delivery System Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Ophthalmic Drug Delivery System Sales Market Share by Type (2021-2032)
  9. 5.3 Global Ophthalmic Drug Delivery System Price by Type
6 Ophthalmic Drug Delivery System Market by Application
  1. 6.1 Global Ophthalmic Drug Delivery System Revenue by Application
  2. 6.1.1 Global Ophthalmic Drug Delivery System Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Ophthalmic Drug Delivery System Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Ophthalmic Drug Delivery System Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Ophthalmic Drug Delivery System Sales by Application
  6. 6.2.1 Global Ophthalmic Drug Delivery System Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Ophthalmic Drug Delivery System Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Ophthalmic Drug Delivery System Sales Market Share by Application (2021-2032)
  9. 6.3 Global Ophthalmic Drug Delivery System Price by Application
7 Company Profiles
  1. 7.1 Aero Pump GmbH
  2. 7.1.1 Aero Pump GmbH Company Information
  3. 7.1.2 Aero Pump GmbH Business Overview
  4. 7.1.3 Aero Pump GmbH Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Aero Pump GmbH Ophthalmic Drug Delivery System Product Portfolio
  6. 7.1.5 Aero Pump GmbH Recent Developments
  7. 7.2 AptarGroup
  8. 7.2.1 AptarGroup Company Information
  9. 7.2.2 AptarGroup Business Overview
  10. 7.2.3 AptarGroup Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 AptarGroup Ophthalmic Drug Delivery System Product Portfolio
  12. 7.2.5 AptarGroup Recent Developments
  13. 7.3 Bausch Health
  14. 7.3.1 Bausch Health Company Information
  15. 7.3.2 Bausch Health Business Overview
  16. 7.3.3 Bausch Health Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bausch Health Ophthalmic Drug Delivery System Product Portfolio
  18. 7.3.5 Bausch Health Recent Developments
  19. 7.4 Becton Dickinson & Company
  20. 7.4.1 Becton Dickinson & Company Company Information
  21. 7.4.2 Becton Dickinson & Company Business Overview
  22. 7.4.3 Becton Dickinson & Company Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Becton Dickinson & Company Ophthalmic Drug Delivery System Product Portfolio
  24. 7.4.5 Becton Dickinson & Company Recent Developments
  25. 7.5 Biocorp Production
  26. 7.5.1 Biocorp Production Company Information
  27. 7.5.2 Biocorp Production Business Overview
  28. 7.5.3 Biocorp Production Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Biocorp Production Ophthalmic Drug Delivery System Product Portfolio
  30. 7.5.5 Biocorp Production Recent Developments
  31. 7.6 Clearside Biomedical
  32. 7.6.1 Clearside Biomedical Company Information
  33. 7.6.2 Clearside Biomedical Business Overview
  34. 7.6.3 Clearside Biomedical Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Clearside Biomedical Ophthalmic Drug Delivery System Product Portfolio
  36. 7.6.5 Clearside Biomedical Recent Developments
  37. 7.7 Envisia Therapeutics
  38. 7.7.1 Envisia Therapeutics Company Information
  39. 7.7.2 Envisia Therapeutics Business Overview
  40. 7.7.3 Envisia Therapeutics Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Envisia Therapeutics Ophthalmic Drug Delivery System Product Portfolio
  42. 7.7.5 Envisia Therapeutics Recent Developments
  43. 7.8 EyePoint Pharmaceuticals, Inc.
  44. 7.8.1 EyePoint Pharmaceuticals, Inc. Company Information
  45. 7.8.2 EyePoint Pharmaceuticals, Inc. Business Overview
  46. 7.8.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Product Portfolio
  48. 7.8.5 EyePoint Pharmaceuticals, Inc. Recent Developments
  49. 7.9 Gaplast GmbH
  50. 7.9.1 Gaplast GmbH Company Information
  51. 7.9.2 Gaplast GmbH Business Overview
  52. 7.9.3 Gaplast GmbH Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Gaplast GmbH Ophthalmic Drug Delivery System Product Portfolio
  54. 7.9.5 Gaplast GmbH Recent Developments
  55. 7.10 Gerresheimer
  56. 7.10.1 Gerresheimer Company Information
  57. 7.10.2 Gerresheimer Business Overview
  58. 7.10.3 Gerresheimer Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Gerresheimer Ophthalmic Drug Delivery System Product Portfolio
  60. 7.10.5 Gerresheimer Recent Developments
  61. 7.11 Graybug Vision
  62. 7.11.1 Graybug Vision Company Information
  63. 7.11.2 Graybug Vision Business Overview
  64. 7.11.3 Graybug Vision Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Graybug Vision Ophthalmic Drug Delivery System Product Portfolio
  66. 7.11.5 Graybug Vision Recent Developments
  67. 7.12 Kedalion Therapeutics
  68. 7.12.1 Kedalion Therapeutics Company Information
  69. 7.12.2 Kedalion Therapeutics Business Overview
  70. 7.12.3 Kedalion Therapeutics Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Kedalion Therapeutics Ophthalmic Drug Delivery System Product Portfolio
  72. 7.12.5 Kedalion Therapeutics Recent Developments
  73. 7.13 Mati Therapeutics, Inc.,
  74. 7.13.1 Mati Therapeutics, Inc., Company Information
  75. 7.13.2 Mati Therapeutics, Inc., Business Overview
  76. 7.13.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Product Portfolio
  78. 7.13.5 Mati Therapeutics, Inc., Recent Developments
  79. 7.14 Nemera
  80. 7.14.1 Nemera Company Information
  81. 7.14.2 Nemera Business Overview
  82. 7.14.3 Nemera Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Nemera Ophthalmic Drug Delivery System Product Portfolio
  84. 7.14.5 Nemera Recent Developments
  85. 7.15 Nipro Corporation
  86. 7.15.1 Nipro Corporation Company Information
  87. 7.15.2 Nipro Corporation Business Overview
  88. 7.15.3 Nipro Corporation Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Nipro Corporation Ophthalmic Drug Delivery System Product Portfolio
  90. 7.15.5 Nipro Corporation Recent Developments
  91. 7.16 Ocular Therapeutix
  92. 7.16.1 Ocular Therapeutix Company Information
  93. 7.16.2 Ocular Therapeutix Business Overview
  94. 7.16.3 Ocular Therapeutix Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Ocular Therapeutix Ophthalmic Drug Delivery System Product Portfolio
  96. 7.16.5 Ocular Therapeutix Recent Developments
  97. 7.17 Ocumedic, Inc.
  98. 7.17.1 Ocumedic, Inc. Company Information
  99. 7.17.2 Ocumedic, Inc. Business Overview
  100. 7.17.3 Ocumedic, Inc. Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Ocumedic, Inc. Ophthalmic Drug Delivery System Product Portfolio
  102. 7.17.5 Ocumedic, Inc. Recent Developments
  103. 7.18 Owen Mumford
  104. 7.18.1 Owen Mumford Company Information
  105. 7.18.2 Owen Mumford Business Overview
  106. 7.18.3 Owen Mumford Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Owen Mumford Ophthalmic Drug Delivery System Product Portfolio
  108. 7.18.5 Owen Mumford Recent Developments
  109. 7.19 Re-Vana Therapeutics
  110. 7.19.1 Re-Vana Therapeutics Company Information
  111. 7.19.2 Re-Vana Therapeutics Business Overview
  112. 7.19.3 Re-Vana Therapeutics Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Re-Vana Therapeutics Ophthalmic Drug Delivery System Product Portfolio
  114. 7.19.5 Re-Vana Therapeutics Recent Developments
  115. 7.20 Santen Pharmaceutical
  116. 7.20.1 Santen Pharmaceutical Company Information
  117. 7.20.2 Santen Pharmaceutical Business Overview
  118. 7.20.3 Santen Pharmaceutical Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Santen Pharmaceutical Ophthalmic Drug Delivery System Product Portfolio
  120. 7.20.5 Santen Pharmaceutical Recent Developments
  121. 7.21 Silgan Holdings Inc.
  122. 7.21.1 Silgan Holdings Inc. Company Information
  123. 7.21.2 Silgan Holdings Inc. Business Overview
  124. 7.21.3 Silgan Holdings Inc. Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Silgan Holdings Inc. Ophthalmic Drug Delivery System Product Portfolio
  126. 7.21.5 Silgan Holdings Inc. Recent Developments
  127. 7.22 Taiwan Liposome
  128. 7.22.1 Taiwan Liposome Company Information
  129. 7.22.2 Taiwan Liposome Business Overview
  130. 7.22.3 Taiwan Liposome Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Taiwan Liposome Ophthalmic Drug Delivery System Product Portfolio
  132. 7.22.5 Taiwan Liposome Recent Developments
  133. 7.23 Terumo Corporation
  134. 7.23.1 Terumo Corporation Company Information
  135. 7.23.2 Terumo Corporation Business Overview
  136. 7.23.3 Terumo Corporation Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Terumo Corporation Ophthalmic Drug Delivery System Product Portfolio
  138. 7.23.5 Terumo Corporation Recent Developments
  139. 7.24 West Pharmaceutical Services, Inc.
  140. 7.24.1 West Pharmaceutical Services, Inc. Company Information
  141. 7.24.2 West Pharmaceutical Services, Inc. Business Overview
  142. 7.24.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Product Portfolio
  144. 7.24.5 West Pharmaceutical Services, Inc. Recent Developments
8 North America
  1. 8.1 North America Ophthalmic Drug Delivery System Market Size by Type
  2. 8.1.1 North America Ophthalmic Drug Delivery System Revenue by Type (2021-2032)
  3. 8.1.2 North America Ophthalmic Drug Delivery System Sales by Type (2021-2032)
  4. 8.1.3 North America Ophthalmic Drug Delivery System Price by Type (2021-2032)
  5. 8.2 North America Ophthalmic Drug Delivery System Market Size by Application
  6. 8.2.1 North America Ophthalmic Drug Delivery System Revenue by Application (2021-2032)
  7. 8.2.2 North America Ophthalmic Drug Delivery System Sales by Application (2021-2032)
  8. 8.2.3 North America Ophthalmic Drug Delivery System Price by Application (2021-2032)
  9. 8.3 North America Ophthalmic Drug Delivery System Market Size by Country
  10. 8.3.1 North America Ophthalmic Drug Delivery System Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Ophthalmic Drug Delivery System Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Ophthalmic Drug Delivery System Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Ophthalmic Drug Delivery System Market Size by Type
  2. 9.1.1 Europe Ophthalmic Drug Delivery System Revenue by Type (2021-2032)
  3. 9.1.2 Europe Ophthalmic Drug Delivery System Sales by Type (2021-2032)
  4. 9.1.3 Europe Ophthalmic Drug Delivery System Price by Type (2021-2032)
  5. 9.2 Europe Ophthalmic Drug Delivery System Market Size by Application
  6. 9.2.1 Europe Ophthalmic Drug Delivery System Revenue by Application (2021-2032)
  7. 9.2.2 Europe Ophthalmic Drug Delivery System Sales by Application (2021-2032)
  8. 9.2.3 Europe Ophthalmic Drug Delivery System Price by Application (2021-2032)
  9. 9.3 Europe Ophthalmic Drug Delivery System Market Size by Country
  10. 9.3.1 Europe Ophthalmic Drug Delivery System Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Ophthalmic Drug Delivery System Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Ophthalmic Drug Delivery System Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Ophthalmic Drug Delivery System Market Size by Type
  2. 10.1.1 China Ophthalmic Drug Delivery System Revenue by Type (2021-2032)
  3. 10.1.2 China Ophthalmic Drug Delivery System Sales by Type (2021-2032)
  4. 10.1.3 China Ophthalmic Drug Delivery System Price by Type (2021-2032)
  5. 10.2 China Ophthalmic Drug Delivery System Market Size by Application
  6. 10.2.1 China Ophthalmic Drug Delivery System Revenue by Application (2021-2032)
  7. 10.2.2 China Ophthalmic Drug Delivery System Sales by Application (2021-2032)
  8. 10.2.3 China Ophthalmic Drug Delivery System Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ophthalmic Drug Delivery System Market Size by Type
  2. 11.1.1 Asia Ophthalmic Drug Delivery System Revenue by Type (2021-2032)
  3. 11.1.2 Asia Ophthalmic Drug Delivery System Sales by Type (2021-2032)
  4. 11.1.3 Asia Ophthalmic Drug Delivery System Price by Type (2021-2032)
  5. 11.2 Asia Ophthalmic Drug Delivery System Market Size by Application
  6. 11.2.1 Asia Ophthalmic Drug Delivery System Revenue by Application (2021-2032)
  7. 11.2.2 Asia Ophthalmic Drug Delivery System Sales by Application (2021-2032)
  8. 11.2.3 Asia Ophthalmic Drug Delivery System Price by Application (2021-2032)
  9. 11.3 Asia Ophthalmic Drug Delivery System Market Size by Country
  10. 11.3.1 Asia Ophthalmic Drug Delivery System Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Ophthalmic Drug Delivery System Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Ophthalmic Drug Delivery System Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ophthalmic Drug Delivery System Market Size by Type
  2. 12.1.1 SAMEA Ophthalmic Drug Delivery System Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Ophthalmic Drug Delivery System Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Ophthalmic Drug Delivery System Price by Type (2021-2032)
  5. 12.2 SAMEA Ophthalmic Drug Delivery System Market Size by Application
  6. 12.2.1 SAMEA Ophthalmic Drug Delivery System Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Ophthalmic Drug Delivery System Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Ophthalmic Drug Delivery System Price by Application (2021-2032)
  9. 12.3 SAMEA Ophthalmic Drug Delivery System Market Size by Country
  10. 12.3.1 SAMEA Ophthalmic Drug Delivery System Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Ophthalmic Drug Delivery System Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Ophthalmic Drug Delivery System Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Ophthalmic Drug Delivery System Value Chain Analysis
  2. 13.1.1 Ophthalmic Drug Delivery System Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Ophthalmic Drug Delivery System Production Mode & Process
  6. 13.2 Ophthalmic Drug Delivery System Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Ophthalmic Drug Delivery System Distributors
  9. 13.2.3 Ophthalmic Drug Delivery System Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst